List of Contributors

Jennifer E. Adair,    Fred Hutchinson Cancer Research Center, Seattle, Washington

Jahangir Ahmed,    Queen Mary University of London, London, United Kingdom

Ghassan Alusi,    Queen Mary University of London, London, United Kingdom

Doron Amit,    Hebrew University of Jerusalem, Jerusalem, Israel

Scott J. Antonia,    University of South Florida, Tampa, Florida

Dominick L. Auci,    University of Washington, Seattle, Washington

David A. August,    Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Rutger K. Balvers,    Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

Lajos Baranyi,    Lentigen Corporation, Gaithersburg, Maryland

Brian C. Beard,    Fred Hutchinson Cancer Research Center, Seattle, Washington

Sebastian Brennig,    Research Group Reprogramming and Gene Therapy, REBIRTH Cluster-of-Excellence and Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany

Elizabeth K. Broussard,    University of Washington, Seattle, Washington

Paul D. Bryson,    University of Southern California, Los Angeles, California

Andrew P. Byrnes,    Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland

Denise L. Cecil,    University of Washington, Seattle, Washington

Tim Chan,    Intrexon Corporation, Germantown, Maryland

Charlie Comins,    University of Surrey, Guildford, United Kingdom

Christiaan R. de Vries,    Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Robert S. DiPaola,    Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Clemens M.F. Dirven,    Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

Mary L. Disis,    University of Washington, Seattle, Washington

Boro Dropulic,    Lentigen Corporation, Gaithersburg, Maryland

Heather Embree,    Lentigen Corporation, Gaithersburg, Maryland

Michael W. Epperly,    University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Juan Fueyo,    University of Texas M. D. Anderson Cancer Center, Houston, Texas

Toshiyoshi Fujiwara,    Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Hua Fung,    Case Western Reserve University and University Hospital of Cleveland, Cleveland, Ohio

Emmanuel Gabriel,    Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Vidya Ganapath,    Rutgers, The State University of New Jersey, Piscataway, New Jersey

Stanton L. Gerson,    Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio

Steven Gill,    Bristol University, AMBI LABS, Southmead Hospital, Bristol, United Kingdom

Michal Gilon,    Hebrew University of Jerusalem, Jerusalem, Israel

Joe Goldufsky,    Rush University Medical Center, Chicago, Illinois

Candelaria Gomez-Manzano,    University of Texas M. D. Anderson Cancer Center, Houston, Texas

Jennifer Rubin Grandis,    University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Joel S. Greenberger,    University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

John W. Greiner,    National Institutes of Health, Bethesda, Maryland

Maneesh Gujrati,    Case Western Reserve University, Cleveland, Ohio

James L. Gulley,    National Institutes of Health, Bethesda, Maryland

Amin Hajitou,    Phage Therapy Group, Imperial College London, London, United Kingdom

Kevin J. Harrington,    Chester Beatty Laboratories, London, United Kingdom

Arash Hatefi,    Rutgers, The State University of New Jersey, Piscataway, New Jersey

Loree C. Heller,    Old Dominion University, Norfolk, Virginia

Richard Heller,    Old Dominion University, Norfolk, Virginia

Akseli Hemminki,    University of Helsinki, Helsinki, Finland

Otto Hemminki,    University of Helsinki, Helsinki, Finland

Ronald B. Herberman,    Intrexon Corporation, Germantown, Maryland

Daniel Herendeen,    University of Washington, Seattle, Washington

Abraham Hochberg,    Hebrew University of Jerusalem, Jerusalem, Israel

James W. Hodge,    National Institutes of Health, Bethesda, Maryland

Gregory E. Holt,    University of Washington, Seattle, Washington

Ying Huang,    Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland

Insoo Hyun,    Case Western Reserve University School of Medicine, Cleveland, Ohio

Hong Jiang,    University of Texas M. D. Anderson Cancer Center, Houston, Texas

Shunsuke Kagawa,    Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Zahra Karjoo,    Rutgers, The State University of New Jersey, Piscataway, New Jersey

Howard Kaufman,    Rush University Medical Center, Chicago, Illinois

Chien-Chih Ke,    National Yang Ming University, Taipei, Taiwan

Hans-Peter Kiem,    Fred Hutchinson Cancer Research Center, Seattle, Washington

Jonathan Kimmelman,    McGill University, Montreal, Quebec, Canada

Sarah R. Klein,    University of Texas M. D. Anderson Cancer Center, Houston, Texas

Shinji Kuroda,    Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Seong Young Kwon,    Chonnam National University Medical School, Jeonnam, Republic of Korea

Nico Lachmann,    Research Group Reprogramming and Gene Therapy, REBIRTH Cluster-of-Excellence and Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany

Hermann Lage,    Institute of Pathology, Berlin, Germany

Martine L.M. Lamfers,    Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

Edmund C. Lattime,    Rutgers Cancer Institute of New Jersey and Rutgers...